L-type Ca2+ channel sparklets revealed by TIRF microscopy in mouse urinary bladder smooth muscle

Platelet-activating factor (PAF) enhances guinea pig detrusor smooth muscle contractile activities by stimulating voltage-dependent Ca2+ channels and store-operated Ca2+ channels

We investigated the extracellular Ca²⁺ influx pathways involved in platelet-activating factor (PAF)-enhanced guinea pig detrusor smooth muscle (DSM) contractile activities. One micromolar PAF-enhanced DSM contractile activities were completely inhibited by extracellular Ca²⁺ removal and strongly suppressed by voltage-dependent Ca²⁺ channel (VDCC) inhibitors. PAF-enhanced DSM contractile activities remaining in the presence of verapamil (10 μM) were not inhibited by LOE-908 (30 μM, an inhibitor of receptor-operated Ca²⁺ channels (ROCCs)), but were almost completely inhibited by SKF-96365 (30 μM, an inhibitor of store-operated Ca²⁺ channels (SOCCs) and ROCCs). These results suggest that VDCCs and SOCCs are responsible for PAF-enhanced DSM contractile activities.

Pharmacological Studies on the Ca2+ Influx Pathways in Platelet-Activating Factor (PAF)-Induced Mouse Urinary Bladder Smooth Muscle Contraction

Platelet-activating factor (PAF) not only acts as a mediator of platelet aggregation, inflammation, and allergy responses but also as a constrictor of various smooth muscle (SM) tissues, including gastrointestinal, tracheal/bronchial, and pregnancy uterine SMs. Previously, we reported that PAF induces basal tension increase (BTI) and oscillatory contraction (OC) in mouse urinary bladder SM (UBSM). In this study, we examined the Ca²⁺ influx pathways involved in PAF-induced BTI and OC in the mouse UBSM. PAF (10^-6 M) induced BTI and OC in mouse UBSM. However, the PAF-induced BTI and OC were completely suppressed by extracellular Ca²⁺ removal. PAF-induced BTI and OC frequencies were markedly suppressed by voltage-dependent Ca²⁺ channel (VDCC) inhibitors (verapamil (10^-5 M), diltiazem (10^-5 M), and nifedipine (10^-7 M)). However, these VDCC inhibitors had a minor effect on the PAF-induced OC amplitude. The PAF-induced OC amplitude in the presence of verapamil (10^-5 M) was strongly suppressed by SKF-96365 (3 × 10^-5 M), an inhibitor of receptor-operated Ca²⁺ channel (ROCC) and store-operated Ca²⁺ channel (SOCC), but not by LOE-908 (3 × 10^-5 M) (an inhibitor of ROCC). Overall, PAF-induced BTI and OC in mouse UBSM depend on Ca²⁺ influx and the main Ca²⁺ influx pathways in PAF-induced BTI and OC may be VDCC and SOCC. Of note, VDCC may be involved in PAF-induced BTI and OC frequency, and SOCC might be involved in PAF-induced OC amplitude.

The KV 7 channel activator retigabine suppresses mouse urinary bladder afferent nerve activity without affecting detrusor smooth muscle K+ channel currents

KEY POINTS

K_V 7 channels are a family of voltage-dependent K⁺ channels expressed in many cell types, which open in response to membrane depolarization to regulate cell excitability. Drugs that target K_V 7 channels are used clinically to treat epilepsy. Interestingly, these drugs also cause urinary retention, but it was unclear how. In this study, we focused on two possible mechanisms by which retigabine could cause urinary retention: by decreasing smooth muscle excitability, or by decreasing sensory nerve outflow. Urinary bladder smooth muscle had no measurable K_V 7 channel currents. However, the K_V 7 channel agonist retigabine nearly abolished sensory nerve outflow from the urinary bladder during bladder filling. We conclude that K_V 7 channel activation likely affects urinary bladder function by blocking afferent nerve outflow to the brain, which is key to sensing bladder fullness.

ABSTRACT

K_V 7 channels are voltage-dependent K⁺ channels that open in response to membrane depolarization to regulate cell excitability. K_V 7 activators, such as retigabine, were used to treat epilepsy but caused urinary retention. Using electrophysiological recordings from freshly isolated mouse urinary bladder smooth muscle (UBSM) cells, isometric contractility of bladder strips, and ex vivo measurements of bladder afferent activity, we explored the role of K_V 7 channels as regulators of murine urinary bladder function. The K_V 7 activator retigabine (10 μM) had no effect on voltage-dependent K⁺ currents or resting membrane potential of UBSM cells, suggesting that these cells lacked retigabine-sensitive K_V 7 channels. The K_V 7 inhibitor XE-991 (10 μM) inhibited UBSM K⁺ currents; the properties of these currents, however, were typical of K_V 2 channels and not K_V 7 channels. Retigabine inhibited voltage-dependent Ca²⁺ channel (VDCC) currents and reduced steady-state contractions to 60 mM KCl in bladder strips, suggesting that reduction in VDCC current was sufficient to directly affect UBSM function. To determine if retigabine altered ex vivo bladder sensory outflow, we measured afferent activity during simulated transient contractions (TCs) of the bladder wall. Simulated TCs caused bursts of afferent activity that were nearly abolished by retigabine. The effects of retigabine were blocked by co-incubation with XE-991, suggesting specific activation of K_V 7 channels on afferent nerves. These results indicate that retigabine primarily affects urinary bladder function by inhibiting TC generation and afferent nerve activity, which are key to sensing bladder fullness. Any direct inhibition of UBSM contractility is likely to be from non-specific effects on VDCCs and K_V 2 channels.

Activity and Ca²⁺ regulate the mobility of TRPV1 channels in the plasma membrane of sensory neurons

TRPV1 channels are gated by a variety of thermal, chemical, and mechanical stimuli. We used optical recording of Ca²⁺ influx through TRPV1 to measure activity and mobility of single TRPV1 molecules in isolated dorsal root ganglion neurons and cell lines. The opening of single TRPV1 channels produced sparklets, representing localized regions of elevated Ca²⁺. Unlike sparklets reported for L-type Ca²⁺ channels, TRPV4 channels, and AchR channels, TRPV1 channels diffused laterally in the plasma membrane as they gated. Mobility was highly variable from channel-to-channel and, to a smaller extent, from cell to cell. Most surprisingly, we found that mobility decreased upon channel activation by capsaicin, but only in the presence of extracellular Ca²⁺. We propose that decreased mobility of open TRPV1 could act as a diffusion trap to concentrate channels in cell regions with high activity.

DOI:http://dx.doi.org/10.7554/eLife.03819.001

Cells rely on proteins called receptors to keep them informed about what is going on around them. These receptors, which are embedded in the surface of the cell, detect and respond to specific chemical signals. It is known that receptors move around the cell surface as they search for particular chemical signals, but these movements have not been widely studied in experiments.

Senning and Gordon have now investigated the movements of receptors called TRPV1 channels that can detect a chemical called capsaicin. This receptor contains an ion channel that is usually closed. However, when the receptor is activated this channel opens and allows calcium ions to enter the cell.

In the experiments the receptors were tagged with a fluorescent marker, and a fluorescent calcium dye was used to indicate when the channel had been activated by capsaicin. This allowed the function of the receptors to be followed in real time. The experiments were performed on nerve cells taken from mice and in cell culture lines derived from neurons and kidney cells.

Senning and Gordon showed that at first the receptors moved around freely on the surface of the cell, with the degree of mobility varying from cell to cell and also from receptor to receptor. However, when a receptor detected a capsaicin molecule and opened, it tended to move more slowly when calcium ions were present outside the cells.

Further research is needed to explore the mechanism that prevents the receptor from moving. However, since calcium ions are involved in a wide range of processes in the nervous system, it is thought that this mechanism ensures that the receptors concentrate in regions of high neuronal activity.

DOI:http://dx.doi.org/10.7554/eLife.03819.002